The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB(2) receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy

BACKGROUND: Chemotherapeutic agents produce dose-limiting peripheral neuropathy through mechanisms that remain poorly understood. We previously showed that AM1710, a cannabilactone CB(2) agonist, produces antinociception without producing central nervous system (CNS)-associated side effects. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Liting, Guindon, Josée, Vemuri, V Kiran, Thakur, Ganesh A, White, Fletcher A, Makriyannis, Alexandros, Hohmann, Andrea G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502129/
https://www.ncbi.nlm.nih.gov/pubmed/22998838
http://dx.doi.org/10.1186/1744-8069-8-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502129/
https://www.ncbi.nlm.nih.gov/pubmed/22998838
http://dx.doi.org/10.1186/1744-8069-8-71

Ejemplares similares